Included in the formulation
АТХ:J.06.B.C Other immunoglobulins
Pharmacodynamics:Has antibacterial effect. The preparation contains immunoglobulins containing antibodies to pathogenic Proteus vulgaris (serogroup 043) and Proteus mirabilis (serogroup 035) and Escherichia coli (serogroup 026, 055, 0111, 0119).
Pharmacokinetics:Not studied.
Indications:Used to normalize the intestinal microflora.
XVI.P75-P78.P78.9 Disorder of digestive system in perinatal period, unspecified
Contraindications:Individual intolerance to cow's milk.
Carefully:Individual intolerance to cow's milk.
Pregnancy and lactation:Pregnancy and lactation: recommendations for FDA - Category A. There are no restrictions to use during pregnancy and lactation.
Dosing and Administration:The drug is applied 30 minutes prior to feeding.
Newborns: 1 dose 1-2 times a day; 1-6 months: 1 dose 2 times a day; 6 months - 1 year: 2 doses 2 times a day; over 1 year: 2 doses 2-3 times a day.
The course of treatment is 1-14 days.
The highest daily dose: 6 doses.
The highest single dose: 2 doses.
Side effects:Allergic reactions.
Interaction:Compatible with any medication. At simultaneous application with bifidumbacterinum efficiency raises.
Special instructions:It is used as a part of complex etiological therapy against the background of desensitizing drugs.